Axogen Inc Stock Today
| AXGN Stock | USD 13.34 0.24 1.83% |
Performance3 of 100
| Odds Of DistressLess than 12
|
Axogen is selling at 13.34 as of the 24th of November 2024; that is 1.83 percent increase since the beginning of the trading day. The stock's open price was 13.1. Axogen has less than a 12 % chance of experiencing some financial distress in the next two years of operation, but did not have a good performance during the last 90 trading days. Equity ratings for Axogen Inc are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 26th of August 2024 and ending today, the 24th of November 2024. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 27th of March 1990 | Category Healthcare | Classification Health Care |
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. It provides its products to hospitals, surgery centers, and military hospitals plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and various oral and maxillofacial surgeons in the United States, Canada, Germany, the United Kingdom and other European countries, South Korea, and internationally. The company has 44.01 M outstanding shares of which 1.13 M shares are presently shorted by private and institutional investors with about 3.16 trading days to cover. More on Axogen Inc
Moving against Axogen Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Axogen Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| CEO and President and Director | Karen Zaderej | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NASDAQ Composite, NASDAQ Health Care, NASDAQ Composite Total, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsAxogen can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Axogen's financial leverage. It provides some insight into what part of Axogen's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Axogen Inc (AXGN) is traded on NASDAQ Exchange in USA. It is located in 13631 Progress Boulevard, Alachua, FL, United States, 32615 and employs 426 people. Axogen is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 587.07 M. Axogen Inc conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 44.01 M outstanding shares of which 1.13 M shares are presently shorted by private and institutional investors with about 3.16 trading days to cover.
Axogen Inc currently holds about 58.03 M in cash with (5.72 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.37.
Check Axogen Probability Of Bankruptcy
Ownership AllocationAxogen holds a total of 44.01 Million outstanding shares. The majority of Axogen Inc outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Axogen Inc to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Axogen. Please pay attention to any change in the institutional holdings of Axogen Inc as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Axogen Ownership Details
Axogen Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Tocqueville Asset Management L.p. | 2024-09-30 | 694.9 K | |
| Millennium Management Llc | 2024-06-30 | 681.8 K | |
| Dimensional Fund Advisors, Inc. | 2024-09-30 | 680.8 K | |
| D. E. Shaw & Co Lp | 2024-09-30 | 634.3 K | |
| Deutsche Bank Ag | 2024-06-30 | 574.7 K | |
| Bank Of America Corp | 2024-06-30 | 470.7 K | |
| Prudential Financial Inc | 2024-09-30 | 434 K | |
| Armistice Capital, Llc | 2024-09-30 | 400.1 K | |
| Northern Trust Corp | 2024-09-30 | 377.3 K | |
| Morgan Stanley - Brokerage Accounts | 2024-06-30 | 5 M | |
| First Light Asset Management, Llc | 2024-09-30 | 4.1 M |
Axogen Historical Income Statement
Axogen Stock Against Markets
Axogen Corporate Executives
Elected by the shareholders, the Axogen's board of directors comprises two types of representatives: Axogen inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Axogen. The board's role is to monitor Axogen's management team and ensure that shareholders' interests are well served. Axogen's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Axogen's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Peter Mariani | Ex CFO | Profile |
Already Invested in Axogen Inc?
The danger of trading Axogen Inc is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Axogen is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Axogen. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Axogen Inc is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Axogen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Axogen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Axogen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Axogen Inc Stock: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Axogen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Axogen. If investors know Axogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Axogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.33) | Revenue Per Share 4.16 | Quarterly Revenue Growth 0.179 | Return On Assets (0.03) | Return On Equity (0.15) |
The market value of Axogen Inc is measured differently than its book value, which is the value of Axogen that is recorded on the company's balance sheet. Investors also form their own opinion of Axogen's value that differs from its market value or its book value, called intrinsic value, which is Axogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Axogen's market value can be influenced by many factors that don't directly affect Axogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Axogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Axogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Axogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.